drugset / Trial / NCT03229785
Quality of Life Improvements With Cord Blood Plasma
NaSingle-groupOpen-labelSupportive care
Summary
This study aims to look at whether human umbilical cord blood plasma (HUCBP) is safe for intravascular (iv) administration; and whether it provides any reversal of frailty or other age-related biological measures.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2019-01-31
- Completion
- 2019-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Umbilical Cord Blood Plasma | Unknown | 50 ml | Intravenous |
Indications
No indication recorded.